Skip to main content
Cell Cycle logoLink to Cell Cycle
. 2015 Jan 15;14(4):526–532. doi: 10.1080/15384101.2014.995490

Emerging role of RNA•DNA hybrids in C9orf72-linked neurodegeneration

Jiou Wang 1,2,*, Aaron R Haeusler 1,2, Eric AJ Simko 1,2
PMCID: PMC4614400  PMID: 25590632

Abstract

RNA plays an active role in structural polymorphism of the genome through the formation of stable RNA•DNA hybrids (R-loops). R-loops can modulate normal physiological processes and are also associated with pathological conditions, such as those related to nucleotide repeat expansions. A guanine-rich hexanucleotide repeat expansion in chromosome 9 open reading frame 72 (C9orf72) has been linked to a spectrum of neurological conditions including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Here we discuss the possible roles, both locally and genome-wide, of R-loops that may arise from the C9orf72 hexanucleotide repeat. R-loops have the potential to influence the pathological processes identified in many repeat expansion diseases, such as repeat instability, transcriptional dysregulation, epigenetic modification, and antisense-mediated gene regulation. We propose that, given the wide-ranging consequences of R-loops in the cell, these structures could underlie multiple pathological processes in C9orf72-linked neurodegeneration.

Keywords: ALS, antisense, C9orf72, FTD, G-quadruplex, histone methylation, R-loop, RNA

Abbreviations

ALS

amyotrophic lateral sclerosis

AOA2

ataxia with oculomotor apraxia type 2

C9orf72

chromosome 9 open reading frame 72

CpG island

cytosine-phosphate-guanine island

FTD

frontotemporal dementia

HRE

hexanucleotide repeat expansion

Introduction

Hybrids formed between RNA and DNA occur naturally in both prokaryotes and eukaryotes. As necessary steps in the flow of genetic information, RNA•DNA duplexes are produced during transcription, reverse transcription (viral and telomeric), DNA replication (RNA primer), and by co- and post-transcriptional rehybridization. These hybrids are generally thought to be small in size and quickly resolved by the appropriate cellular mechanisms. Nevertheless, stable and long-lasting RNA•DNA hybrids with important functions have been observed (see reviews1-3).

RNA•DNA hybridization, in the context of duplex DNA, occurs when RNA displaces a strand of the original DNA duplex, forming an RNA•DNA hybrid/single-stranded DNA structure referred to as an R-loop (Fig. 1).4 R-loop formation is enhanced by high guanine (G) content5 and transcription-linked negative DNA supercoiling.6 One possible explanation for the increased formation of R-loops in regions with high guanine content is that G-rich single-stranded DNA is prone to forming stable secondary structures. These structures can include hairpins and stacks of Hoogsteen base pair-stabilized guanine tetrads known as G-quadruplexes. The ability of the displaced single-stranded DNA to form these stable structures is thought to increase the probability of RNA•DNA hybrid formation. Transcription-linked negative supercoiling promotes unwinding of the DNA duplex, increasing accessibility of the DNA strands for RNA binding and promoting formation of strand-stabilizing G-quadruplex formation.7 Once formed, RNA•DNA duplexes can be highly stable,8,9 and the guanine-cytosine hydrogen bonds of Watson-Crick base pairing in the G-rich sequences further promote the stabilization of the RNA•DNA duplexes. In addition to Watson-Crick base pairing in hybrid helices, intermolecular G-quadruplexes between RNA and DNA have been proposed to further stabilize G-rich hybrids.10,11

Figure 1.

Figure 1.

A proposed model for the emerging roles of RNA DNA hybrids in C9orf72 repeat-expansion-associated diseases. Repeat-containing RNAs (red) invade DNA duplexes (blue) and form RNA•DNA hybrids, R-loops. The R-loops promote repeat instability and may in turn be influenced by variable repeat lengths. These R-loops can initiate transcriptional repression through several regulatory mechanisms, including polymerase pausing/termination, antisense transcription, and histone/DNA methylation. The formation of R-loops is closely tied to multiple aspects of RNA metabolism, including transcription, splicing, degradation, and nuclear transport. Transcripts containing the C9orf72 repeats could act locally upon the C9orf72 gene or globally at other genomic sites. Thus, R-loops may contribute to disease through reduced expression of C9orf72 gene products as well as acquired nucleic acid-based toxicity.

R-loops have been identified across species and, at least in the budding yeast, are associated with all the RNA polymerases including Pol I, II, III, and even mitochondrial polymerase.12 R-loops are naturally occuring structures that are associated with transcription but can also be formed by the post-transcriptional rehybridization of single-stranded RNA with cDNA.13 Diverse biological functions of R-loops have been proposed, including roles in transcriptional regulation, DNA replication, telomere elongation, and genome editing.1-3 Not surprisingly, the cell has evolved specialized mechanisms for regulating the formation and dissolution of R-loops. For example, the RecA/Rad51 family protein, which facilitates strand exchange in homologous recombination14, has been found to promote R-loop formation in bacteria and yeasts.13,15,16 In the flowering plant Arabidopsis, a homeodomain protein AtNDX was observed to bind to the single-stranded DNA and stabilize R-loops.17 Conversely, several proteins are known to prevent the accumulation of R-loops, including the helicase senataxin18 and the RNA•DNA hybrid-specific endonucleases RNase H1 and H2.19 In addition, perturbation at multiple steps in RNA processing, including transcription, splicing, degradation, and nuclear transport, leads to increased R-loop formation,20-22 suggesting that a balance in R-loop equilibrium is closely tied to RNA homeostasis.

Optimal regulation of R-loops is thought to be necessary for cellular health and proper function. Accordingly, perturbation of R loop-associated factors has been linked to cancer and neurodegenerative diseases. Here we briefly summarize recent advances in R-loop biology and its potential mechanistic link to C9orf72 hexanucleotide repeat expansion (HRE) diseases, with the aim of providing a current perspective and initiating a discussion on the potentially important connection between R-loop dysregulation and this form of neurodegeneration.

C9orf72 repeat expansion diseases

An expanded hexanucleotide repeat in C9orf72, (GGGGCC)n, is the most common genetic mutation identified to date in the motor neuron degenerative disease amyotrophic lateral sclerosis (ALS).23,24 The C9orf72 HRE also represents the most common genetic cause of frontotemporal dementia (FTD), which is characterized by degeneration of the frontal and temporal lobes of the brain and is the second most common type of dementia in people younger than 65.25 Furthermore, the C9orf72 HRE is linked to rare cases of other neurological conditions, including Alzheimer's disease,26-29 Huntington's disease,30 multiple system atrophy,31 depressive pseudodementia,32 bipolar disorder,33-35 and schizophrenia.36 Given these wide-ranging implications, understanding the molecular mechanisms of C9orf72 HRE-associated diseases has become a significant challenge in the study of neurodegeneration. Currently, the proposed mechanisms for C9orf72 HRE-linked pathogenesis include the a loss of function of the C9orf72 gene products and a gained toxicity of the transcribed HRE, with the latter including RNA toxicity and unconventional poly di-peptide products translated from the repeats.37-41 However, these pathogenic mechanisms are not mutually exclusive, and studies of their molecular bases are currently underway.

Recently, the C9orf72 HRE was shown to be capable of readily forming R-loops in vitro.42,43 The properties of (GGGGCC)n repeats are highly conducive to R-loop formation at the C9orf72 HRE. The DNA (GGGGCC)n repeats can form stable secondary structures, including hairpins and G-quadruplexes,42,44,45 which are thought to stabilize the displaced DNA strand and therefore increase stability of the RNA•DNA hybrid duplex. Once formed, the GGGGCC•CCCCGG RNA•DNA hybrid is predicted to be highly stable, given its complete GC content. C9orf72 HRE repeat length is highly unstable and there is increasing evidence that the expansion leads to reduced gene expression, epigenetic modification, and bidirectional transcription. As we describe below, these cellular processes have been shown in other instances to involve R-loops. Therefore, we propose that R-loop formation as a consequence of the C9orf72 HRE may underly multiple processes in C9orf72-linked neurodegeneration (Fig. 1).

Repeat instability

An important step in understanding C9orf72-linked diseases is elucidating the origin of the repeat expansion. The typical human C9orf72 allele contains 2-25 units of the GGGGCC repeat46. ALS and FTD-linked alleles have been found to contain up to thousands of repeat units. Interestingly, genetic analysis of the C9orf72 HRE mutations has identified a common haplotype, but the lengths of the C9orf72 HRE vary among carriers. This observation suggests a scenario of either unstable repeats from a single founder47 or a predisposing haplotype shared by different founders.48 Genetic anticipation, which describes earlier symptom onset in subsequent generations, has been observed in other repeat expansion diseases, but it has yet to be established for the C9orf72 syndrome. It has been suggested that in individual patients carrying the C9orf72 HRE, cells from different tissues or different regions of the brain exhibit varying lengths of repeats.48-50 Irrespective of the neuronal or glial origins of these brain cells, the repeat instability could arise during somatic cell division, post-mitotic stages, or both, as seen in other repeat expansion diseases.

Short-repeat (microsatellite) expansions are responsible for nearly 40 different types of genetic disorders, primarily neurological and neuromuscular disorders.51-54 Most of these diseases are associated with repeat instability, showing either an expansion or contraction of the repeat region. The instability has been linked to atypical DNA secondary structures that are prone to erroneous replication or repair.55,56 Also, the formation of R-loops enhances the instability of the (CAG)n repeat,57 although it remains unclear how R-loops promote repeat instability. A recent study by Reddy et al. suggests that R-loops play a role in repeat instability that is dependent on their processing by certain cellular factors.43 This study showed that incubating transcriptionally generated R-loops with mammalian cell lysates in a cell-free system could induce a high frequency of repeat length variations on the R-loop-bearing DNA template. Interestingly, double R-loops generated by bidirectional transcription in vitro were much more susceptible to repeat instability than were single R-loops of either direction. Of note, the C9orf72 HRE, (GGGGCC)n appeared to be more prone to such R-loop-dependent repeat instability than was the (CAG)n used in the study.43

Much remains to be learned about the genesis and mechanism of C9orf72 hexanucleotide repeat instability in native settings. The occurance of repeat instability depends on cell types, model organisms, developmental stages, and aging, suggesting that a number of cellular factors exist to regulate the instability. Studying these factors in both in vitro and in vivo models, as well as characterizing the instability in patients, will deepen our understanding of the intergenerational and somatic repeat instability observed for patients.

Transcription

R-loops have increasingly been shown to mediate transcriptional pausing or stalling,58,59 which may contribute to a reduction in the C9orf72 gene expression in patients’ cells carrying the repeat expansion. The C9orf72 gene uses alternative start and splicing to produce at least 3 transcript variants. V2 (NM_018325.3) and V3 (NM_001256054.1) encode a long isoform of the protein, and V1 (NM_145005.5) encodes a short isoform.24 According to common annotation, the C9orf72 HRE, (GGGGCC)n, is located either in intron 1, as for transcripts V1 and V3, or at a promoter region, as for transcript V2. However, the presence of the expanded repeat apparently complicates regulation of C9orf72 gene expression. For example, there is a reported increase in the usage of alternative transcriptional start sites upstream of the expanded repeat.60 In addition, most studies report a reduction in individual or all variants of C9orf72,24,37,42,61-68 with a consensus for markedly reduced levels of V2, which is the predominant variant among the 3 transcripts. There is increasing evidence that R-loops can repress transcription, suggesting that this mechanism of repression may contribute to the observed reduction in C9orf72 gene expression in patients’ cells.

R-loops have been shown to negatively regulate transcription at the steps of initiation, elongation, and termination in vitro and in vivo.69 R-loop-mediated transcriptional regulation has been observed in both normal genes and expanded repeat loci. For instance, the (GAA)n repeat in Friedreich's ataxia has been shown to form R-loops70,71 and directly inhibit polymerase processitivity.72-75 Consistent with reduced C9orf72 gene expression in patients’ cells, the (GGGGCC)n repeat exhibits trancriptional stalling in vitro in a length-dependent manner, which may be mediated, in part, by R-loops formed on the repeat sequences.42 In additon to their direct impact on RNA polymerases, R-loops are also proposed to mediate other mechanisms of transcriptional repression, such as histone methylation.

Histone and DNA methylations

Multiple lines of evidence suggest that R-loops mediate transcriptional silencing through histone methylation.58,59,76 A (CGG)n expansion, linked to Fragile X syndrome, is positioned within the 5’ untranslated region of transcripts from the fragile X mental retardation 1 (FMR1) gene and leads to silencing of the FMR1 gene. R-loops were recently shown to form at this (CGG)n expansion in patients’ cells.58,76,77 Using a human embryonic stem cell-derived neuronal culture system, Colak et al. demonstrated that the formation of RNA•DNA hybrids coincided with the initiation of transcriptional silencing of FMR1.76 Moreover, this formation of RNA•DNA hybrids was associated with histone H3 dimethylated on lysine 9 (H3K9me2) marks, which have been implicated in R-loop-mediated transcriptional regulation.58,59,76 Silencing of the FMR1 gene by the expanded repeats depended on neuronal differentiation,76 and it still remains to be determined how R-loops are regulated during development and other cellular processes.

In another recent study by Groh et al., R-loops were found to form in vivo on (GAA)n repeats in the cells of patients with Friedreich's ataxia.58 These (GAA)n R-loops were transcription-dependent and colocalized with the repressive histone modification H3K9me2. Furthermore, R-loop formation appeared to precede H3K9 dimethylation.58 Trimethylation of H3K9, H3K27, and H4K20 has been associated with reduced C9orf72 gene expression in ALS/FTD patient brain tissues and fibroblasts carrying the expanded repeat.64 Additionally, H3S10 phosphorylation is thought to influence the modification of surrounding residues and modulate gene expression through activation or repression.78 Repressive H3S10 phosphorylation was found to be associated with R-loops,79 and it will be interesting to determine whether these marks are present at the expanded C9orf72 locus. In brief, repressive histone modifications at the C9orf72 HRE locus may be initiated as a result of the formation of R-loops, but future studies will be needed to assess this connection.

In addition to histone modification, DNA methylation has been associated with the expanded C9orf72 repeats in the cells of ALS and FTD patients.62,68,80-82 There are 2 cytosine-phosphate-guanine (CpG) islands flanking the C9orf72 repeat locus. The CpG island upstream of the repeat has been found to have increased methylation in a subset of expanded repeat carriers,62,68,81 while the CpG island downstream of the repeat is unmethylated. The expanded repeat itself is not apparently hypermethylated.68 Interestingly, R-loops are often found at CpG islands and are proposed to suppress DNA methylation.5 Understanding the relationship between R-loops and DNA/histone modification at the C9orf72 locus, as well as the contributions of these factors to disease, will be an important task in future investigation.

Antisense transcript-mediated gene regulation

Production of both sense and antisense transcripts from the expanded C9orf72 hexanucleotide repeats has been observed in patients’ cells.39,83-86 A genome-wide study in yeast found that RNA•DNA hybrids are enriched in genes that produce antisense transcripts and that the expression of these genes is regulated by the hybrids.87 A recent study by Skourti-Stathaki et al. reported that R-loops induce antisense transcription, which leads to RNA interference-dependent repressive histone marks over mammalian gene terminators.59 R-loops were previously found to be enriched at G-rich RNA polymerase II transcription terminators18 and, consistent with a role of R-loops in mediating repressive histone marks,58,76 the R-loops at terminators promoted H3K9me2 marks and heterochromatin structures.59 Interestingly, this process was mediated by R-loop-dependent antisense transcription, which led to the formation of double-stranded RNAs and the recruitment of DICER, Argonautes, G9a histone lysine methyltransferase, and heterochromatin protein 1γ.59 Given that the C9orf72 hexanucleotide repeats have been found to produce antisense transcripts and also display histone methylation, it is possible that R-loop-dependent transcriptional silencing of the C9orf72 gene is influenced by a mechanism involving these antisense transcripts.

Genome-wide trans-acting RNA•DNA hybrids

Thus far, we have mainly discussed R-loops formed in cis, with the RNA moiety either transcriptionally coupled or rehybridized to its DNA template. RNAs can also act in trans and form RNA•DNA hybrids at distant genomic sites.13 This possibility would be increased for repeat-containing RNAs if their cDNA sequences occur at genomic sites other than the original gene. For example, based on alignment searches in the National Center for Biotechnology Information databases, the C9orf72 (GGGGCC)n repeat, ranging from 3 to 8 units, occurs tens of times in the human genome, a frequency much higher than would be expected by chance based on the size of the genome. In addition, the repetitive nature of the repeat RNAs may facilitate the formation of intermolecular RNA•DNA hybrids in trans via non-Watson-Crick hydrogen bonds. It is likely that hybrid secondary structures such as hairpins or G-quadruplexes can be formed between GC-rich RNAs and DNAs even if their sequences are not completely complementary. Irrespective of their specific conformations, genome-wide trans-acting RNA•DNA hybrids constitute a possible mechanism for gain-of-function RNA toxicity in the pathogenesis of repeat expansion diseases.

RNA•DNA hybrids in relation to ALS genes

There are several clues that suggest a critical link between R-loops and the genes implicated in ALS and other neurological conditions. The best characterized case is senataxin, an RNA helicase that has an established function in resolving R-loops.18,88,89 Mutations in senataxin have been linked to ataxia with oculomotor apraxia type 2 (AOA2) and juvenile amyotrophic lateral sclerosis type 4(ALS4).90 Although the mechanisms of these diseases and the full spectrum of senataxin's functions remain to be elucidated, the R-loop-related transcription and DNA repair functions suggest specific avenues of investigation.

In another instance of R-loop connections to neurodegeneration, a recent study by Salvi et al. showed that the yeast homolog of ataxin-2, Pbp1, functions to inhibit formation of RNA•DNA hybrids.91 A trinucleotide repeat (CAG)n expansion that encodes a polyglutamine stretch in the ataxin-2 gene is linked to the neurodegenerative disease spinocerebellar ataxia type 2,92-94 and intermediate-length repeat expansions in ataxin-2 increase the risk for ALS.95. Recently, the intermediate-length repeat in ataxin-2 was observed to be a potential disease modifier in C9orf72 expansion carriers and there is a co-occurrence of the 2 expansion mutations in ALS/FTD patients.96,97 Human ataxin-2 has been implicated in multiple RNA-processing functions; however, its potential function in modulating R-loops, if confirmed, could provide a mechanistic link among these neurodegenerative diseases.

Finally, RNA•DNA hybrid-specific nuclease, RNase H2, is linked to a severe neurological disease Aicardi-Goutières syndrome.98 Mutations in 3 components of an RNase H2 enzyme complex have been linked to the disease.99 The immunological symptoms of the disease suggest that increased endogenous RNA•DNA hybrids can inadvertently trigger innate immune responses.99 Immune activation, in particular inflammation, is also an important aspect of the pathogenesis of neurodegenerative diseases such as ALS/FTD,100 suggesting another potential link between R-loop formation and neurodegeneration.

Perspectives

Neurodegenerative disorders that arise as a consequence of the C9orf72 hexanucleotide repeat expansion are fundamentally nucleic acid diseases. R-loop formation, a seemingly robust feature of the C9orf72 repeat, may mediate both loss-of-function and gain-of-function pathogenic mechanisms. The C9orf72 repeat provides exciting new opportunites for future in vitro and in vivo studies that will expand our understanding of RNA•DNA hybrid structures in health and disease..Furthermore, despite a common genetic cause, there is significant variation in disease pathology and symptoms linked to the C9orf72 HRE. Formation of RNA•DNA hybrid structures at the C9orf72 locus may trigger multiple divergent pathogenic cascades that contribute to the diversity of C9orf72 syndrome. Given the upstream position in pathogenic cascades, the C9orf72 RNA•DNA hybrid may also prove to be a valuable therapeutic target.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Acknowledgments

We thank PS Miller for reading the manuscript and members of Wang laboratory for discussion.

Funding

We thank National Institutes of Health for funding support (NS07432).

References

  • 1. Skourti-Stathaki K, Proudfoot NJ. A double-edged sword: R loops as threats to genome integrity and powerful regulators of gene expression. Genes Dev 2014; 28:1384-96; PMID:24990962; http://dx.doi.org/ 10.1101/gad.242990.114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Groh M, Gromak N. Out of balance: R-loops in human disease. PLoS Genet 2014; 10:e1004630; PMID:25233079; http://dx.doi.org/ 10.1371/journal.pgen.1004630 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Aguilera A, García-Muse T. R loops: from transcription byproducts to threats to genome stability. Mol Cell 2012; 46:115-24; PMID:22541554; http://dx.doi.org/ 10.1016/j.molcel.2012.04.009 [DOI] [PubMed] [Google Scholar]
  • 4. Thomas M, White RL, Davis RW. Hybridization of RNA to double-stranded DNA: formation of R-loops. Proc Natl Acad Sci USA 1976; 73:2294-8; PMID:781674 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Ginno PA, Lott PL, Christensen HC, Korf I, Chédin F. R-loop formation is a distinctive characteristic of unmethylated human CpG island promoters. Mol Cell 2012; 45:814-25; PMID:22387027; http://dx.doi.org/ 10.1016/j.molcel.2012.01.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Massé E, Drolet M. Escherichia coli DNA topoisomerase I inhibits R-loop formation by relaxing transcription-induced negative supercoiling. J Biochem 1999; 274:16659-64; PMID:10347234 [DOI] [PubMed] [Google Scholar]
  • 7. Sun D, Hurley LH. The importance of negative superhelicity in inducing the formation of G-quadruplex and i-motif structures in the c-Myc promoter: implications for drug targeting and control of gene expression. J Med Chem 2009; 52:2863-74; PMID:19385599; http://dx.doi.org/ 10.1021/jm900055s [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Roberts RW, Crothers DM. Stability and properties of double and triple helices: dramatic effects of RNA or DNA backbone composition. Science 1992; 258:1463-6; PMID:1279808; http://dx.doi.org/ 10.1126/science.1279808 [DOI] [PubMed] [Google Scholar]
  • 9. Sugimoto N, Nakano S, Katoh M, Matsumura A, Nakamuta H, Ohmichi T, Yoneyama M, Sasaki M. Thermodynamic parameters to predict stability of RNA/DNA hybrid duplexes. Biochemistry 1995; 34:11211-6; PMID:7545436; http://dx.doi.org/ 10.1021/bi00035a029 [DOI] [PubMed] [Google Scholar]
  • 10. Xu Y, Kimura T, Komiyama M. Human telomere RNA and DNA form an intermolecular G-quadruplex. Nucleic Acids Symp Ser (Oxf) 2008; 169-70 ; PMID:18776307; http://dx.doi.org/ 10.1093/nass/nrn086 [DOI] [PubMed] [Google Scholar]
  • 11. Wanrooij PH, Uhler JP, Shi Y, Westerlund F, Falkenberg M, Gustafsson CM. A hybrid G-quadruplex structure formed between RNA and DNA explains the extraordinary stability of the mitochondrial R-loop. Nucleic Acids Res 2012; 40:10334-44; PMID:22965135; http://dx.doi.org/ 10.1093/nar/gks802 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Hage El A, Webb S, Kerr A, Tollervey D. Genome-wide distribution of RNA-DNA hybrids identifies RNase H targets in tRNA genes, retrotransposons and mitochondria. PLoS Genet 2014; 10:e1004716; PMID:25357144; http://dx.doi.org/ 10.1371/journal.pgen.1004716 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Wahba L, Gore SK, Koshland D. The homologous recombination machinery modulates the formation of RNA-DNA hybrids and associated chromosome instability. Elife 2013; 2:e00505; PMID:23795288; http://dx.doi.org/ 10.7554/eLife.00505 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Krejci L, Altmannova V, Spirek M, Zhao X. Homologous recombination and its regulation. Nucleic Acids Res 2012; 40:5795-818; PMID:22467216; http://dx.doi.org/ 10.1093/nar/gks270 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Kasahara M, Clikeman JA, Bates DB, Kogoma T. RecA protein-dependent R-loop formation in vitro. Genes Dev 2000; 14:360-5; PMID:10673507 [PMC free article] [PubMed] [Google Scholar]
  • 16. Zaitsev EN, Kowalczykowski SC. A novel pairing process promoted by Escherichia coli RecA protein: inverse DNA and RNA strand exchange. Genes Dev 2000; 14:740-9; PMID:10733533 [PMC free article] [PubMed] [Google Scholar]
  • 17. Sun Q, Csorba T, Skourti-Stathaki K, Proudfoot NJ, Dean C. R-loop stabilization represses antisense transcription at the arabidopsis FLC locus. Science 2013; 340:619-21; PMID:23641115; http://dx.doi.org/ 10.1126/science.1234848 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Skourti-Stathaki K, Proudfoot NJ, Gromak N. Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination. Mol Cell 2011; 42:794-805; PMID:21700224; http://dx.doi.org/ 10.1016/j.molcel.2011.04.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Cerritelli SM, Crouch RJ. Ribonuclease H: the enzymes in eukaryotes. FEBS J 2009; 276:1494-505; PMID:19228196; http://dx.doi.org/ 10.1111/j.1742-4658.2009.06908.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Huertas P, Aguilera A. Cotranscriptionally formed DNA:RNA hybrids mediate transcription elongation impairment and transcription-associated recombination. Mol Cell 2003; 12:711-21; PMID:14527416; http://dx.doi.org/ 10.1016/j.molcel.2003.08.010 [DOI] [PubMed] [Google Scholar]
  • 21. Li XL, Manley JL. Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability. Cell 2005; 122:365-78; PMID:16096057; http://dx.doi.org/ 10.1016/j.cell.2005.06.008 [DOI] [PubMed] [Google Scholar]
  • 22. Wahba L, Amon JD, Koshland D, Vuica-Ross M. RNase H and multiple RNA biogenesis factors cooperate to prevent RNA:DNA hybrids from generating genome instability. Mol Cell 2011; 44:978-88; PMID:22195970; http://dx.doi.org/ 10.1016/j.molcel.2011.10.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, et al. . A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011; 72:257-68; PMID:21944779; http://dx.doi.org/ 10.1016/j.neuron.2011.09.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Dejesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, et al. . Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011; 72:245-56; PMID:21944778; http://dx.doi.org/ 10.1016/j.neuron.2011.09.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Rademakers R. C9orf72 repeat expansions in patients with ALS and FTD. Lancet Neurol 2012; 11:297-8; PMID:22406229; http://dx.doi.org/ 10.1016/S1474-4422(12)70046-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Rollinson S, Halliwell N, Young K, Callister JB, Toulson G, Gibbons L, Davidson YS, Robinson AC, Gerhard A, Richardson A, et al. . Analysis of the hexanucleotide repeat in C9ORF72 in Alzheimer's disease. Neurobiol Aging 2012; 33:1846.e5-6; PMID:22410647 [DOI] [PubMed] [Google Scholar]
  • 27. Kohli MA, John-Williams K, Rajbhandary R, Naj A, Whitehead P, Hamilton K, Carney RM, Wright C, Crocco E, Gwirtzman HE, et al. . Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians. Neurobiol Aging 2012; 33:2527.e1-2; PMID:23107433; http://dx.doi.org/ 10.1016/j.neurobiolaging.2012.10.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Majounie E, Abramzon Y, Renton AE, Perry R, Bassett SS, Pletnikova O, Troncoso JC, Hardy J, Singleton AB, Traynor BJ. Repeat expansion in C9ORF72 in Alzheimer's disease. New Engl J Med 2012; 366:283-4; PMID:22216764; http://dx.doi.org/ 10.1056/NEJMc1113592 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Harms M, Benitez BA, Cairns N, Cooper B, Cooper P, Mayo K, Carrell D, Faber K, Williamson J, Bird T, et al. . C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease. JAMA Neurol 2013; 70:736-41; PMID:23588422; http://dx.doi.org/ 10.1001/2013.jamaneurol.537 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Hensman Moss DJ, Poulter M, Beck J, Hehir J, Polke JM, Campbell T, Adamson G, Mudanohwo E, McColgan P, Haworth A, et al. . C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology 2014; 82:292-9; PMID:24363131; http://dx.doi.org/ 10.1212/WNL.0000000000000061 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Goldman JS, Quinzii C, Dunning-Broadbent J, Waters C, Mitsumoto H, Brannagan TH, Cosentino S, Huey ED, Nagy P, Kuo S-H. Multiple system atrophy and amyotrophic lateral sclerosis in a family with hexanucleotide repeat expansions in c9orf72. JAMA Neurol 2014; 71:771-4; PMID:24733620; http://dx.doi.org/ 10.1001/jamaneurol.2013.5762 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Bieniek KF, van Blitterswijk M, Baker MC, Petrucelli L, Rademakers R, Dickson DW. Expanded C9ORF72 hexanucleotide repeat in depressive pseudodementia. JAMA Neurol 2014; 71:775-81; PMID:24756204; http://dx.doi.org/ 10.1001/jamaneurol.2013.6368 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Floris G, Borghero G, Cannas A, Stefano FD, Murru MR, Corongiu D, Cuccu S, Tranquilli S, Marrosu MG, Chiò A, et al. . Bipolar affective disorder preceding frontotemporal dementia in a patient with C9ORF72 mutation: is there a genetic link between these two disorders? J Neurol 2013; 260:1155-7; PMID:23314407; http://dx.doi.org/ 10.1007/s00415-013-6833-2 [DOI] [PubMed] [Google Scholar]
  • 34. Meisler MH, Grant AE, Jones JM, Lenk GM, He F, Todd PK, Kamali M, Albin RL, Lieberman AP, Langenecker SA, et al. . C9ORF72 expansion in a family with bipolar disorder. Bipolar Disord 2013; 15:326-32; PMID:23551834; http://dx.doi.org/ 10.1111/bdi.12063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Galimberti D, Reif A, Dell'Osso B, Palazzo C, Villa C, Fenoglio C, Kittel-Schneider S, Leonhard C, Olmes DG, Serpente M, et al. . C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder. Bipolar Disord 2014; 16:448-9; PMID:24329881; http://dx.doi.org/ 10.1111/bdi.12169 [DOI] [PubMed] [Google Scholar]
  • 36. Galimberti D, Reif A, Dell'Osso B, Kittel-Schneider S. The C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia. Neurobiol Aging 2014; 35:1214.e7-e10; PMID:24387986; http://dx.doi.org/ 10.1016/j.neurobiolaging.2013.12.004 [DOI] [PubMed] [Google Scholar]
  • 37. Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, Schmid B, Kretzschmar HA, Cruts M, van Broeckhoven C, et al. . The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 2013; 339:1335-8; PMID:23393093; http://dx.doi.org/ 10.1126/science.1232927 [DOI] [PubMed] [Google Scholar]
  • 38. Ash PEA, Bieniek KF, Gendron TF, Caulfield T, Lin W-L, Dejesus-Hernandez M, van Blitterswijk MM, Jansen-West K, Paul JW. III, Rademakers R, et al. . Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 2013; 77:639-46; PMID:23415312; http://dx.doi.org/ 10.1016/j.neuron.2013.02.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Zu T, Liu Y, Bañez-Coronel M, Reid T, Pletnikova O, Lewis J, Miller TM, Harms MB, Falchook AE, Subramony SH, et al. . RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci USA 2013; 110:E4968-77; PMID:24248382; http://dx.doi.org/ 10.1073/pnas.1315438110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Kwon I, Xiang S, Kato M, Wu L, Theodoropoulos P, Wang T, Kim J, Yun J, Xie Y, McKnight SL. Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science 2014; 345:1139-45; PMID:25081482; http://dx.doi.org/ 10.1126/science.1254917 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Mizielinska S, Grönke S, Niccoli T, Ridler CE, Clayton EL, Devoy A, Moens T, Norona FE, Woollacott IOC, Pietrzyk J, et al. . C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science 2014; 345:1192-4; PMID:25103406; http://dx.doi.org/ 10.1126/science.1256800 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Haeusler AR, Donnelly CJ, Periz G, Simko EAJ, Shaw PG, Kim M-S, Maragakis NJ, Troncoso JC, Pandey A, Sattler R, et al. . C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 2014; 507:195-200; PMID:24598541; http://dx.doi.org/ 10.1038/nature13124 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Reddy K, Schmidt MHM, Geist JM, Thakkar NP, Panigrahi GB, Wang Y-H, Pearson CE. Processing of double-R-loops in (CAG)·(CTG) and C9orf72 (GGGGCC)·(GGCCCC) repeats causes instability. Nucleic Acids Res 2014; 42:10473-87; PMID:25147206; http://dx.doi.org/ 10.1093/nar/gku658 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Fratta P, Mizielinska S, Nicoll AJ, Zloh M, Fisher EMC, Parkinson G, Isaacs AM. C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes. Sci Rep 2012; 2:1016; PMID:23264878; http://dx.doi.org/ 10.1038/srep01016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Reddy K, Zamiri B, Stanley SYR, Macgregor RB, Pearson CE. The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures. J Biol Chem 2013; 288:9860-6; PMID:23423380; http://dx.doi.org/ 10.1074/jbc.C113.452532 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Rutherford NJ, Heckman MG, Dejesus-Hernandez M, Baker MC, Soto-Ortolaza AI, Rayaprolu S, Stewart H, Finger E, Volkening K, Seeley WW, et al. . Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype. Neurobiol Aging 2012; 33:2950.e5-7; PMID:22840558 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Smith BN, Newhouse S, Shatunov A, Vance C, Topp S, Johnson L, Miller J, Lee Y, Troakes C, Scott KM, et al. . The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder. Eur J Hum Genet 2012; 21:102-8; PMID:22692064; http://dx.doi.org/ 10.1038/ejhg.2012.98 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Fratta P, Polke JM, Newcombe J, Mizielinska S, Lashley T, Poulter M, Beck J, Preza E, Devoy A, Sidle K, et al. . Screening a UK amyotrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansion. Neurobiol Aging 2014; 36:546.e1-7; PMID:25179228; http://dx.doi.org/ 10.1016/j.neurobiolaging.2014.07.037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. van Blitterswijk M, Dejesus-Hernandez M, Niemantsverdriet E, Murray ME, Heckman MG, Diehl NN, Brown PH, Baker MC, Finch NA, Bauer PO, et al. . Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study. Lancet Neurol 2013; 12:978-88; PMID:24011653; http://dx.doi.org/ 10.1016/S1474-4422(13)70210-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Dols-Icardo O, García-Redondo A, Rojas-García R, Sanchez-Valle R, Noguera A, Gómez-Tortosa E, Pastor P, Hernández I, Esteban-Pérez J, Suárez-Calvet M, et al. . Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia. Hum Mol Genet 2014; 23:749-54; PMID:24057670; http://dx.doi.org/ 10.1093/hmg/ddt460 [DOI] [PubMed] [Google Scholar]
  • 51. Mirkin SM. Expandable DNA repeats and human disease. Nature 2007; 447:932-40; PMID:17581576; http://dx.doi.org/ 10.1038/nature05977 [DOI] [PubMed] [Google Scholar]
  • 52. Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci 2007; 30:575-621; PMID:17417937; http://dx.doi.org/ 10.1146/annurev.neuro.29.051605.113042 [DOI] [PubMed] [Google Scholar]
  • 53. La Spada AR, Taylor JP. Repeat expansion disease: progress and puzzles in disease pathogenesis. Nat Rev Genet 2010; 11:247-58; PMID:20177426; http://dx.doi.org/ 10.1038/nrg2748 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Todd PK, Paulson HL. RNA-mediated neurodegeneration in repeat expansion disorders. Ann Neurol 2010; 67:291-300; PMID:20373340 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Pearson CE, Edamura KN, Cleary JD. Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 2005; 6:729-42; PMID:16205713; http://dx.doi.org/ 10.1038/nrg1689 [DOI] [PubMed] [Google Scholar]
  • 56. McMurray CT. Mechanisms of trinucleotide repeat instability during human development. Nat Rev Genet 2010; 11:786-99; PMID:20953213; http://dx.doi.org/ 10.1038/nrg2828 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Lin Y, Dent SYR, Wilson JH, Wells RD, Napierala M. R loops stimulate genetic instability of CTG/CAG repeats. Proc Natl Acad Sci USA 2010; 107:692-7; PMID:20080737; http://dx.doi.org/ 10.1073/pnas.0909740107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Groh M, Lufino MMP, Wade-Martins R, Gromak N. R-loops associated with triplet repeat expansions promote gene silencing in Friedreich ataxia and fragile X syndrome. PLoS Genet 2014; 10:e1004318; PMID:24787137; http://dx.doi.org/ 10.1371/journal.pgen.1004318 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Skourti-Stathaki K, Kamieniarz-Gdula K, Proudfoot NJ. R-loops induce repressive chromatin marks over mammalian gene terminators. Nature 2014; 516:436-9; PMID:25296254; http://dx.doi.org/ 10.1038/nature13787 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Sareen D, O'Rourke JG, Meera P, Muhammad AK, Grant S, Simpkinson M, Bell S, Carmona S, Ornelas L, Sahabian A, et al. . Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med 2013; 5:208ra149-9; PMID:24154603 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, Janssens J, Bettens K, Van Cauwenberghe C, Pereson S, et al. . A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 2012; 11:54-65; PMID:22154785; http://dx.doi.org/ 10.1016/S1474-4422(11)70261-7 [DOI] [PubMed] [Google Scholar]
  • 62. Xi Z, Zinman L, Moreno D, Schymick J, Liang Y, Sato C, Zheng Y, Ghani M, Dib S, Keith J, et al. . Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion. Am J Hum Genet 2013; 92:981-9; PMID:23731538; http://dx.doi.org/ 10.1016/j.ajhg.2013.04.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Ciura S, Lattante S, Le Ber I, Latouche M, Tostivint H, Brice A, Kabashi E. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann Neurol 2013; 74:180-7; PMID:23720273 [DOI] [PubMed] [Google Scholar]
  • 64. Belzil VV, Bauer PO, Prudencio M, Gendron TF, Stetler CT, Yan IK, Pregent L, Daughrity L, Baker MC, Rademakers R, et al. . Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol 2013; 126:895-905; PMID:24166615; http://dx.doi.org/ 10.1007/s00401-013-1199-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Almeida S, Gascon E, Tran H, Chou HJ, Gendron TF, DeGroot S, Tapper AR, Sellier C, Charlet-Berguerand N, Karydas A, et al. . Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol 2013; 126:385-99; PMID:23836290; http://dx.doi.org/ 10.1007/s00401-013-1149-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Donnelly CJ, Zhang P-W, Pham JT, Heusler AR, Mistry NA, Vidensky S, Daley EL, Poth EM, Hoover B, Fines DM, et al. . RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 2013; 80:415-28; PMID:24139042; http://dx.doi.org/ 10.1016/j.neuron.2013.10.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Waite AJ, Bäumer D, East S, Neal J, Morris HR, Ansorge O, Blake DJ. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol Aging 2014; 35:1779. e5-e13; PMID:24559645; http://dx.doi.org/ 10.1016/j.neurobiolaging.2014.01.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Liu EY, Russ J, Wu K, Neal D, Suh E, McNally AG, Irwin DJ, Van Deerlin VM, Lee EB. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD. Acta Neuropathol 2014; 128:525-41; PMID:24806409; http://dx.doi.org/ 10.1007/s00401-014-1286-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Groh M, Silva LM, Gromak N. Mechanisms of transcriptional dysregulation in repeat expansion disorders. Biochem Soc Trans 2014; 42:1123-8; PMID:25110013; http://dx.doi.org/ 10.1042/BST20140049 [DOI] [PubMed] [Google Scholar]
  • 70. Grabczyk E, Mancuso M, Sammarco MC. A persistent RNA.DNA hybrid formed by transcription of the Friedreich ataxia triplet repeat in live bacteria, and by T7 RNAP in vitro. Nucleic Acids Res 2007; 35:5351-9; PMID:17693431; http://dx.doi.org/ 10.1093/nar/gkm589 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Reddy K, Tam M, Bowater RP, Barber M, Tomlinson M, Nichol Edamura K, Wang YH, Pearson CE. Determinants of R-loop formation at convergent bidirectionally transcribed trinucleotide repeats. Nucleic Acids Res 2011; 39:1749-62; PMID:21051337; http://dx.doi.org/ 10.1093/nar/gkq935 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Bidichandani SI, Ashizawa T, Patel PI. The GAA triplet-repeat expansion in friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am J Hum Genet 1998; 62:11-1; PMID:9443873; http://dx.doi.org/ 10.1086/301680 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Ohshima KK, Montermini LL, Wells RDR, Pandolfo MM. Inhibitory effects of expanded GAA.TTC triplet repeats from intron I of the Friedreich ataxia gene on transcription and replication in vivo. J Biochem 1998; 273:14588-95. [DOI] [PubMed] [Google Scholar]
  • 74. Grabczyk E, Usdin K. The GAA*TTC triplet repeat expanded in Friedreich's ataxia impedes transcription elongation by T7 RNA polymerase in a length and supercoil dependent manner. Nucleic Acids Res 2000; 28:2815-22; PMID:10908340; http://dx.doi.org/ 10.1093/nar/28.14.2815 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Krasilnikova MM, Kireeva ML, Petrovic V, Knijnikova N, Kashlev M, Mirkin SM. Effects of Friedreich's ataxia (GAA)n*(TTC)n repeats on RNA synthesis and stability. Nucleic Acids Res 2007; 35:1075-84; PMID:17264130; http://dx.doi.org/ 10.1093/nar/gkl1140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Colak D, Zaninovic N, Cohen MS, Rosenwaks Z, Yang W-Y, Gerhardt J, Disney MD, Jaffrey SR. Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome. Science 2014; 343:1002-5; PMID:24578575; http://dx.doi.org/ 10.1126/science.1245831 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Loomis EW, Sanz LA, Chédin F, Hagerman PJ. Transcription-associated R-loop formation across the human FMR1 CGG-repeat region. PLoS Genet 2014; 10:e1004294-4; PMID:24743386; http://dx.doi.org/ 10.1371/journal.pgen.1004294 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Liokatis S, Stützer A, Elsässer SJ, Theillet F-X, Klingberg R, van Rossum B, Schwarzer D, Allis CD, Fischle W, Selenko P. Phosphorylation of histone H3 Ser10 establishes a hierarchy for subsequent intramolecular modification events. Nat Struct Mol Biol 2012; 19:819-23; PMID:22796964; http://dx.doi.org/ 10.1038/nsmb.2310 [DOI] [PubMed] [Google Scholar]
  • 79. Castellano-Pozo M, Santos-Pereira JM, Rondón AG, Barroso S, Andújar E, Pérez-Alegre M, García-Muse T, Aguilera A. R loops are linked to histone H3 S10 phosphorylation and chromatin condensation. Mol Cell 2013; 52:583-90; PMID:24211264; http://dx.doi.org/ 10.1016/j.molcel.2013.10.006 [DOI] [PubMed] [Google Scholar]
  • 80. Belzil VV, Bauer PO, Gendron TF, Murray ME, Dickson D, Petrucelli L. Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients. Brain Res 2014; 1584:15-21; PMID:24530272; http://dx.doi.org/ 10.1016/j.brainres.2014.02.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Xi Z, Rainero I, Rubino E, Pinessi L, Bruni AC, Maletta RG, Nacmias B, Sorbi S, Galimberti D, Surace EI, et al. . Hypermethylation of the CpG-island near the C9orf72 G4C2-repeat expansion in FTLD patients. Hum Mol Genet 2014; 23:5630-7; PMID:24908669; http://dx.doi.org/ 10.1093/hmg/ddu279 [DOI] [PubMed] [Google Scholar]
  • 82. Russ J, Liu EY, Wu K, Neal D, Suh E, Irwin DJ, McMillan CT, Harms MB, Cairns NJ, Wood EM, et al. . Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier. Acta Neuropathol 2014; 129:39-52; PMID:25388784; http://dx.doi.org/ 10.1007/s00401-014-1365-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Gendron TF, Bieniek KF, Zhang YJ, Jansen-West K. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol 2013; 126:829-44; PMID:24129584; http://dx.doi.org/ 10.1007/s00401-013-1192-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Mori K, Arzberger T, Grässer FA, Gijselinck I, May S, Rentzsch K, Weng S-M, Schludi MH, van der Zee J, Cruts M, et al. . Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol 2013; 126:881-93; PMID:24132570; http://dx.doi.org/ 10.1007/s00401-013-1189-3 [DOI] [PubMed] [Google Scholar]
  • 85. Mizielinska S, Lashley T, Norona FE, Clayton EL, Ridler CE, Pietro Fratta, Isaacs AM. C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci. Acta Neuropathol 2013; 126:845-57; PMID:24170096; http://dx.doi.org/ 10.1007/s00401-013-1200-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Lagier-Tourenne C, Baughn M, Rigo F, Sun S, Liu P, Li H-R, Jiang J, Watt AT, Chun S, Katz M, et al. . Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. PNAS 2013; 110:E4530-9; PMID:24170860; http://dx.doi.org/ 10.1073/pnas.1318835110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87. Chan YA, Aristizabal MJ, Lu PYT, Luo Z, Hamza A, Kobor MS, Stirling PC, Hieter P. Genome-wide profiling of yeast DNA:RNA hybrid prone sites with DRIP-chip. PLoS Genet 2014; 10:e1004288-8; PMID:24743342; http://dx.doi.org/ 10.1371/journal.pgen.1004288 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88. Kim HD, Choe J, Seo YS. The sen1(+) gene of Schizosaccharomyces pombe, a homologue of budding yeast SEN1, encodes an RNA and DNA helicase. Biochemistry 1999; 38:14697-710; PMID:10545196; http://dx.doi.org/ 10.1021/bi991470c [DOI] [PubMed] [Google Scholar]
  • 89. Mischo HE, Gómez-González B, Grzechnik P, Rondón AG, Wei W, Steinmetz L, Aguilera A, Proudfoot NJ. Yeast Sen1 helicase protects the genome from transcription-associated instability. Mol Cell 2011; 41:21-32; PMID:21211720; http://dx.doi.org/ 10.1016/j.molcel.2010.12.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Chen Y-Z, Bennett CL, Huynh HM, Blair IP, Puls I, Irobi J, Dierick I, Abel A, Kennerson ML, Rabi BA, et al. . DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 2004; 74:1128-35; PMID:15106121; http://dx.doi.org/ 10.1086/421054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91. Salvi JS, Chan JNY, Szafranski K, Liu TT, Wu JD, Olsen JB, Khanam N, Poon BPK, Emili A, Mekhail K. Roles for Pbp1 and caloric restriction in genome and lifespan maintenance via suppression of RNA-DNA hybrids. Dev Cell 2014; 30:177-91; PMID:25073155; http://dx.doi.org/ 10.1016/j.devcel.2014.05.013 [DOI] [PubMed] [Google Scholar]
  • 92. Pulst SM, Nechiporuk A, Nechiporuk T, Gispert S, Chen XN, LopesCendes I, Pearlman S, Starkman S, OrozcoDiaz G, Lunkes A, et al. . Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 1996; 14:269-76; PMID:8896555; http://dx.doi.org/ 10.1038/ng1196-269 [DOI] [PubMed] [Google Scholar]
  • 93. Imbert G, Saudou F, Yvert G, Devys D, Trottier Y, Garnier JM, Weber C, Mandel JL, Cancel G, Abbas N, et al. . Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet 1996; 14:285-91; PMID:8896557; http://dx.doi.org/ 10.1038/ng1196-285 [DOI] [PubMed] [Google Scholar]
  • 94. Sanpei K, Takano H, Igarashi S, Sato T, Oyake M, Sasaki H, Wakisaka A, Tashiro K, Ishida Y, Ikeuchi T, et al. . Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet 1996; 14:277-84; PMID:8896556; http://dx.doi.org/ 10.1038/ng1196-277 [DOI] [PubMed] [Google Scholar]
  • 95. Elden AC, Kim H-J, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, et al. . Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 2010; 466:1069-75; PMID:20740007; http://dx.doi.org/ 10.1038/nature09320 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96. van Blitterswijk M, Mullen B, Heckman MG, Baker MC, Dejesus-Hernandez M, Brown PH, Murray ME, Hsiung G-YR, Stewart H, Karydas AM, et al. . Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers. Neurobiol Aging 2014; 35:2421.e13-7; PMID:24866401; http://dx.doi.org/ 10.1016/j.neurobiolaging.2014.04.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97. Lattante S, Millecamps S, Stevanin G, Rivaud-Pechoux S, Moigneu C, Camuzat A, Da Barroca S, Mundwiller E, Couarch P, Salachas F, et al. . Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders. Neurology 2014; 83:990-5; PMID:25098532; http://dx.doi.org/ 10.1212/WNL.0000000000000778 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98. Reijns MAM, Jackson AP. Ribonuclease H2 in health and disease. Biochem Soc Trans 2014; 42:717-25; PMID:25109948; http://dx.doi.org/ 10.1042/BST20140079 [DOI] [PubMed] [Google Scholar]
  • 99. Crow YJ, Leitch A, Hayward BE, Garner A, Parmar R, Griffith E, Ali M, Semple C, Aicardi J, Babul-Hirji R, et al. . Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection. Nat Genet 2006; 38:910-6; PMID:16845400; http://dx.doi.org/ 10.1038/ng1842 [DOI] [PubMed] [Google Scholar]
  • 100. Amor S, Puentes F, Baker D, Van Der Valk P. Inflammation in neurodegenerative diseases. Immunology 2010; 129:154-69; PMID:20561356; http://dx.doi.org/ 10.1111/j.1365-2567.2009.03225.x [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cell Cycle are provided here courtesy of Taylor & Francis

RESOURCES